Wednesday, December 1, 2021
7:00 – 8:00 pm EST
This timely live webinar will provide an overview of the efficacy, safety, side effects, and immune system impact of MS disease-modifying therapies.
With featured speaker:
Edward J. Fox, MD, PhD
Director, MS Clinic of Central Texas
Central Texas Neurology Consultants
Clinical Associate Professor, University of Texas Dell Medical School
The CMSC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The CMSC designates this activity for a maximum of 1.0 contact hours of nursing continuing professional development (NCPD) (1.0 in the area of pharmacology).
This knowledge-based activity, JA4008165-9999-21-041-L01-P, qualifies for 1.0 contact hours (.10 CEUs) of continuing pharmacy education credit.